Although a Mendelian randomization study did not provide substantial evidence to support the positive effect of VEGF on ischemic heart disease (IHD), it cannot eliminate the possibility that some specific types of VEGF might still have a role in the pathology (32). This evidence concerns the gene VEGFA and coronary artery disorder.